VEGF Trap-Eye: New Data Confirm Successes In The Treatment Of Age Related Macular Degeneration
Oct 1st 2008Drug InformationClinical Trials
VEGF Trap-Eye can achieve durable improvements in visual acuity and in biologic measurement parameters in the formation of new blood vessels in the treatment of age-related macular degeneration (AMG). This was shown in the final evaluation of a Phase 2 study presented at the annual meeting of the Retina Society in Scottsdale, Arizona. These parameters include retinal thickness and active choroidal neovascularization lesion size (the damaged part of the retina).
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
